ANAPLASTIC OLIGODENDROGLIOMA AND OLIGOASTROCYTOMA WITHOUT 1P-19Q CO-DELETION: A MONO-INSTITUTIONAL RETROSPECTIVE STUDY

被引：0
|
作者：
Gaviani, P. [1 ]
Simonetti, G. [1 ]
Innocenti, A. [1 ]
Farinotti, M. [1 ]
Finocchiaro, G. [1 ]
Lamperti, E. [1 ]
Botturi, A. [1 ]
Pollo, B. [1 ]
DiMeco, F. [1 ]
Silvani, A. [1 ]
机构：
[1] IRCCS Ist Neurol Carlo Besta, Milan, Italy
来源：
NEURO-ONCOLOGY | 2017年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P10.26
引用
收藏
页码：91 / 91
页数：1
相关论文
共 50 条
  • [31] Regional specificity of 1p/19q co-deletion combined with radiological features for predicting the survival outcomes of anaplastic oligodendroglial tumor patients
    Kai Wang
    Yinyan Wang
    Xing Fan
    Yanong Li
    Xing Liu
    Jiangfei Wang
    Lin Ai
    Jianping Dai
    Tao Jiang
    Journal of Neuro-Oncology, 2018, 136 : 523 - 531
  • [32] Multigene signature for predicting prognosis of patients with 1p19q co-deletion diffuse glioma
    Hu, Xin
    Martinez-Ledesma, Emmanuel
    Zheng, Siyuan
    Kim, Hoon
    Barthel, Floris
    Jiang, Tao
    Hess, Kenneth R.
    Verhaak, Roel G. W.
    NEURO-ONCOLOGY, 2017, 19 (06) : 786 - 795
  • [33] IS LOH 1P/19Q OF PROGNOSTIC RELEVANCE IN OLIGODENDROGLIOMA AND OLIGOASTROCYTOMA-BUT NOT IN PURE ASTROCYTOMA?
    Suchorska, Bogdana
    Mehrkens, Jan H.
    Eigenbrod, Sabina
    Eroes, Christian A.
    Tonn, Joerg C.
    Kretzschmar, Hans A.
    Kreth, Friedrich V.
    NEURO-ONCOLOGY, 2010, 12 : 63 - 63
  • [34] ANAPLASTIC ASTROCYTOMA AND NON-1P/19Q CODELETED ANAPLASTIC OLIGOASTROCYTOMA: LONG-TERM SURVIVAL
    Elena, Pentsova
    Andrew, Lassman
    Anne, Reiner
    Katherine, Panageas
    Lisa, DeAngelis
    NEURO-ONCOLOGY, 2010, 12 : 28 - 28
  • [35] RESULTS OF THE INTERIM ANALYSIS OF THE EORTC RANDOMIZED PHASE III CATNON TRIAL ON CONCURRENT AND ADJUVANT TEMOZOLOMIDE IN ANAPLASTIC GLIOMA WITHOUT 1p/19q CO-DELETION, AN INTERGROUP TRIAL
    van den Bent, Martin
    Vogelbaum, Michael
    Erridge, Sara
    Nowak, Anne
    Sanson, Marc
    Brandes, Alba Ariela
    Wick, Wolfgang
    Clement, Paul
    Baurain, Francois
    Mason, Warren
    Wheeler, Helen
    Chinot, Olivier
    Weller, Michael
    Golfinopoulos, Vassilis
    Aldape, Ken
    Dubbink, Hendrikus
    Wesseling, Pieter
    Gorlia, Thierry
    Baumert, Brigitta
    Kros, Johan
    NEURO-ONCOLOGY, 2016, 18 : 1 - 2
  • [36] Accurate Prediction of 1p/19q Co-deletion in Oligodendrogliomas Using Comprehensive Genomic Profiling
    Wagner, J.
    Bifulco, C.
    Moung-Wen, C.
    Shull, E.
    Pukay, M.
    Ward, T.
    Kaimaktchiev, V.
    Mary, C.
    Piening, B.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2023, 25 (11): : S115 - S115
  • [37] Neoadjuvant temozolomide followed by complete resection of a 1p-and 19q-deleted anaplastic oligoastrocytoma: Case study
    Voloschin, AD
    Louis, DN
    Cosgrove, GR
    Batchelor, TT
    NEURO-ONCOLOGY, 2005, 7 (01) : 97 - 100
  • [38] SHARED ALLELIC LOSSES ON CHROMOSOMES 1P AND 19Q SUGGEST A COMMON ORIGIN OF OLIGODENDROGLIOMA AND OLIGOASTROCYTOMA
    KRAUS, JA
    KOOPMANN, J
    KASKEL, P
    MAINTZ, D
    BRANDNER, S
    SCHRAMM, J
    LOUIS, DN
    WIESTLER, OD
    VONDEIMLING, A
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1995, 54 (01): : 91 - 95
  • [39] Characterizing the breakpoint of 1p/19q co-deletion in glioma with long-read sequence technology
    Sugawa, Masahiro
    Kimura, Keisuke
    Sakamoto, Yoshitaka
    Ochi, Yotaro
    Nakamura, Wataru
    Mateos, Raul
    Chiba, Kenichi
    Okada, Ai
    Okuda, Rurika
    Tsujimura, Taro
    Ohka, Fumiharu
    Motomura, Kazuya
    Kato, Motohiro
    Saito, Ryuta
    Ogawa, Seishi
    Shiraishi, Yuichi
    CANCER SCIENCE, 2025, 116 : 1115 - 1115
  • [40] Results of the interim analysis of the EORTC randomized phase III CATNON trial on concurrent and adjuvant temozolomide in anaplastic glioma without 1p/19q co-deletion: An Intergroup trial.
    Van den Bent, Martin J.
    Erridge, Sara
    Vogelbaum, Michael A.
    Nowak, Anna K.
    Sanson, Marc
    Brandes, Alba Ariela
    Wick, Wolfgang
    Clement, Paul M.
    Baurain, Jean-Francois
    Mason, Warren P.
    Wheeler, Helen
    Chinot, Olivier L.
    Weller, Michael
    Golfinopoulos, Vassilis
    Aldape, Ken
    Dinjens, Winand N. M.
    Wesseling, Pieter
    Gorlia, Thierry
    Kros, Johan M.
    Baumert, Brigitta G.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (18)
12345